Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma.
Ryan H MoyMegan GreallyJoanne F ChouJia LiAvni M DesaiSree B ChalasaniElizabeth WonDavid P KelsenDavid H IlsonYelena Y JanjigianMarinela CapanuGeoffrey Y KuPublished in: Cancer chemotherapy and pharmacology (2022)
NCT03193918. June 19, 2017.
Keyphrases